Related Experiment Videos
[Hormonal disorders in borderline arterial hypertension]
Sovetskaia Meditsina
|January 1, 1989
Summary
Patients with borderline hypertension show elevated adrenocorticotropic hormone (ACTH), hydrocortisone, and somatostatin, alongside increased plasma renin activity. Reduced somatotropin (STH) and insulin levels were also observed in these individuals.
Area of Science:
- Endocrinology
- Cardiovascular Physiology
- Hypertension Research
Context:
- Borderline arterial hypertension (BAH) represents an intermediate stage between normal blood pressure and established hypertension.
- Understanding the hormonal milieu in BAH is crucial for predicting progression to essential hypertension.
Purpose:
- To investigate hormonal and enzymatic profiles in patients with borderline arterial hypertension.
- To explore the potential role of the pressor hormone system in BAH pathogenesis.
Summary:
- Patients with BAH exhibited significantly higher levels of adrenocorticotropic hormone (ACTH), hydrocortisone, and somatostatin compared to normal subjects.
- Elevated plasma renin activity was noted in BAH patients, suggesting activation of the renin-angiotensin-aldosterone system.
- Conversely, levels of somatotropin (STH) and insulin were found to be reduced in the patient group.
Impact:
- Findings suggest that activation of the pressor hormone system may contribute to the development and progression of hypertension.
- This research provides insights into the endocrine dysregulation associated with borderline hypertension.
- Identifying these hormonal markers could aid in early risk stratification for essential hypertension.